Cargando…
Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS
This study aimed to evaluate if the treatment with metformin affects the morphologic structure, endothelial function, angiogenesis, inflammation and oxidation-responsive pathways in the heart of mice with surgically induced endometriosis. B6CBA/F1 mice (n = 37) were divided into four groups; Sham (S...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687337/ https://www.ncbi.nlm.nih.gov/pubmed/36359302 http://dx.doi.org/10.3390/biomedicines10112782 |
_version_ | 1784835979959336960 |
---|---|
author | Martins, Ana Filipa Neto, Ana Catarina Rodrigues, Adriana Raquel Oliveira, Sandra Marisa Sousa-Mendes, Cláudia Leite-Moreira, Adelino Gouveia, Alexandra Maria Almeida, Henrique Neves, Delminda |
author_facet | Martins, Ana Filipa Neto, Ana Catarina Rodrigues, Adriana Raquel Oliveira, Sandra Marisa Sousa-Mendes, Cláudia Leite-Moreira, Adelino Gouveia, Alexandra Maria Almeida, Henrique Neves, Delminda |
author_sort | Martins, Ana Filipa |
collection | PubMed |
description | This study aimed to evaluate if the treatment with metformin affects the morphologic structure, endothelial function, angiogenesis, inflammation and oxidation-responsive pathways in the heart of mice with surgically induced endometriosis. B6CBA/F1 mice (n = 37) were divided into four groups; Sham (S), Metformin (M), Endometriosis (E) and Metformin/Endometriosis (ME). The cross-sectional area of cardiomyocytes was assessed after Hematoxylin–Eosin staining and fibrosis after Picrosirius-Red staining. ET-1, nitric oxide synthases-iNOS and eNOS, and VEGF and VEGFR-2 were detected by immunofluorescence. Semi-quantification of ET-1, eNOS, VEGF, NF-kB, Ikβα and KEAP-1 was performed by Western blotting. MIR199a, MIR16-1, MIR18a, MIR20a, MIR155, MIR200a, MIR342, MIR24-1 and MIR320a were quantified by Real-Time qPCR. The interaction of endometriosis and metformin effects was assessed by a two-way ANOVA test. Compared with the other groups, M-treated mice presented a higher cross-sectional area of cardiomyocytes. Heart fibrosis increased with endometriosis. Treatment of endometriosis with metformin in the ME group downregulates ET-1 and upregulates eNOS expression comparatively with the E group. However, metformin failed to mitigate NF-kB expression significantly incremented by endometriosis. The expression of MIR199a, MIR16-1 and MIR18a decreased with endometriosis, whereas MIR20a showed an equivalent trend, altogether reducing cardioprotection. In summary, metformin diminished endometriosis-associated endothelial dysfunction but did not mitigate the increase in NF-kB expression and cardiac fibrosis in mice with endometriosis. |
format | Online Article Text |
id | pubmed-9687337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96873372022-11-25 Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS Martins, Ana Filipa Neto, Ana Catarina Rodrigues, Adriana Raquel Oliveira, Sandra Marisa Sousa-Mendes, Cláudia Leite-Moreira, Adelino Gouveia, Alexandra Maria Almeida, Henrique Neves, Delminda Biomedicines Article This study aimed to evaluate if the treatment with metformin affects the morphologic structure, endothelial function, angiogenesis, inflammation and oxidation-responsive pathways in the heart of mice with surgically induced endometriosis. B6CBA/F1 mice (n = 37) were divided into four groups; Sham (S), Metformin (M), Endometriosis (E) and Metformin/Endometriosis (ME). The cross-sectional area of cardiomyocytes was assessed after Hematoxylin–Eosin staining and fibrosis after Picrosirius-Red staining. ET-1, nitric oxide synthases-iNOS and eNOS, and VEGF and VEGFR-2 were detected by immunofluorescence. Semi-quantification of ET-1, eNOS, VEGF, NF-kB, Ikβα and KEAP-1 was performed by Western blotting. MIR199a, MIR16-1, MIR18a, MIR20a, MIR155, MIR200a, MIR342, MIR24-1 and MIR320a were quantified by Real-Time qPCR. The interaction of endometriosis and metformin effects was assessed by a two-way ANOVA test. Compared with the other groups, M-treated mice presented a higher cross-sectional area of cardiomyocytes. Heart fibrosis increased with endometriosis. Treatment of endometriosis with metformin in the ME group downregulates ET-1 and upregulates eNOS expression comparatively with the E group. However, metformin failed to mitigate NF-kB expression significantly incremented by endometriosis. The expression of MIR199a, MIR16-1 and MIR18a decreased with endometriosis, whereas MIR20a showed an equivalent trend, altogether reducing cardioprotection. In summary, metformin diminished endometriosis-associated endothelial dysfunction but did not mitigate the increase in NF-kB expression and cardiac fibrosis in mice with endometriosis. MDPI 2022-11-01 /pmc/articles/PMC9687337/ /pubmed/36359302 http://dx.doi.org/10.3390/biomedicines10112782 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Martins, Ana Filipa Neto, Ana Catarina Rodrigues, Adriana Raquel Oliveira, Sandra Marisa Sousa-Mendes, Cláudia Leite-Moreira, Adelino Gouveia, Alexandra Maria Almeida, Henrique Neves, Delminda Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS |
title | Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS |
title_full | Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS |
title_fullStr | Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS |
title_full_unstemmed | Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS |
title_short | Metformin Prevents Endothelial Dysfunction in Endometriosis through Downregulation of ET-1 and Upregulation of eNOS |
title_sort | metformin prevents endothelial dysfunction in endometriosis through downregulation of et-1 and upregulation of enos |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687337/ https://www.ncbi.nlm.nih.gov/pubmed/36359302 http://dx.doi.org/10.3390/biomedicines10112782 |
work_keys_str_mv | AT martinsanafilipa metforminpreventsendothelialdysfunctioninendometriosisthroughdownregulationofet1andupregulationofenos AT netoanacatarina metforminpreventsendothelialdysfunctioninendometriosisthroughdownregulationofet1andupregulationofenos AT rodriguesadrianaraquel metforminpreventsendothelialdysfunctioninendometriosisthroughdownregulationofet1andupregulationofenos AT oliveirasandramarisa metforminpreventsendothelialdysfunctioninendometriosisthroughdownregulationofet1andupregulationofenos AT sousamendesclaudia metforminpreventsendothelialdysfunctioninendometriosisthroughdownregulationofet1andupregulationofenos AT leitemoreiraadelino metforminpreventsendothelialdysfunctioninendometriosisthroughdownregulationofet1andupregulationofenos AT gouveiaalexandramaria metforminpreventsendothelialdysfunctioninendometriosisthroughdownregulationofet1andupregulationofenos AT almeidahenrique metforminpreventsendothelialdysfunctioninendometriosisthroughdownregulationofet1andupregulationofenos AT nevesdelminda metforminpreventsendothelialdysfunctioninendometriosisthroughdownregulationofet1andupregulationofenos |